Meir Schechter

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Chronic Kidney Disease

Tyrosine Kinase

Glycemic Control

Deep Brain Stimulation

Top Venues

Diabetes, obesity & metabolism

Clinical journal of the American Society of Nephrology : CJASN

Annals of internal medicine

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dvora R Sehtman-Shachar, Ilan Yanuv, Meir Schechter, Alisa Fishkin, Genya Aharon-Hananel, Gil Leibowitz, Aliza Rozenberg, Ofri Mosenzon
Normoalbuminuria-is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2024)
Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg, Ilan Yanuv, Dvora R Sehtman-Shachar, Alisa Fishkin, Doron Rosenzweig, Gabriel Chodick, Avraham Karasik, Lawrence A Leiter
Long-Term, Real-World, Kidney Function Changes with SGLT2i versus DPP4i Type 2 Diabetes without Cardiovascular or Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN (2023)
Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg, Ilan Yanuv, Dvora R Sehtman-Shachar, Alisa Fishkin, Doron Rosenzweig, Gabriel Chodick, Avraham Karasik, Lawrence A Leiter
Long-Term, Real-World, Kidney Function Changes with SGLT2i versus DPP4i Type 2 Diabetes without Cardiovascular or Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN (2023)
Meir Schechter, Glenn M Chertow, Hiddo J Lambers Heerspink
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease. Annals of internal medicine 176 (7) (2023)
Meir Schechter, Cheli Melzer Cohen, Tamir Zelter, Ilan Yanuv, Aliza Rozenberg, Gabriel Chodick, Avraham Karasik, Lawrence A Leiter
Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data. Diabetes, obesity & metabolism (2023)
Meir Schechter, Matan Fischer, Lawrence A Leiter
Preventing all-cause hospitalizations in type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A narrative review and proposed clinical approach. Diabetes, obesity & metabolism 24 (6) (2022)
Meir Schechter, Niels Jongs, Glenn M Chertow, Lawrence A Leiter, John Joseph Valentine McMurray, Ricardo Correa-Rotter, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD. Annals of internal medicine (2022)
Jessica Grigoletto, Meir Schechter, Ronit Sharon
Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains. Life (Basel, Switzerland) 12 (1) (2022)
Faina Tsodikov, Meir Schechter, Rebecca Goldsmith, Lilach Peleg, Vered Baloush-Kleinman, Aliza Rozenberg, Ilan Yanuv, Alla Nazarenko, Ofri Mosenzon, Ronit Endevelt
The effect of lifestyle intervention on cardiometabolic risk factors in mental health rehabilitation hostel residents at-risk: a cluster-randomized controlled 15-month trial. International journal of obesity (2005) 46 (5) (2022)